# Ketoanalogue Supplementation for Muscle Protection in CKD 4 and 5 Patients With Moderately Low Protein Diet (KETO-PROT-ACTION)

> **NCT07374042** · PHASE3 · RECRUITING · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 100 (estimated)

## Conditions studied

- Kidney Disease, Chronic

## Interventions

- **DRUG:** Keto Acid

## Key facts

- **NCT ID:** NCT07374042
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-05
- **Primary completion:** 2030-01
- **Final completion:** 2030-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07374042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07374042, "Ketoanalogue Supplementation for Muscle Protection in CKD 4 and 5 Patients With Moderately Low Protein Diet (KETO-PROT-ACTION)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07374042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*